Literature DB >> 18381543

Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.

Farzana D Pashankar1, Judith Carbonella, Alia Bazzy-Asaad, Alan Friedman.   

Abstract

OBJECTIVES: The objectives of this study were (1) to determine the prevalence and risk factors of elevated pulmonary artery pressures in children with homozygous SS or Sbeta(0) thalassemia using Doppler echocardiography and (2) to determine a correlation between abnormal transcranial Doppler examinations and elevated pulmonary artery pressures.
METHODS: Screening echocardiograms were prospectively performed during an annual comprehensive clinic visit on children who were older than 6 years and had homozygous SS or Sbeta(0) thalassemia. Detailed history, examination, and laboratory tests were done, and transcranial Doppler examinations were obtained in children 2 to 14 years of age. Pulmonary hypertension was defined as pulmonary artery systolic pressure of at least 30 mmHg corresponding to a peak tricuspid regurgitant jet velocity of > or = 2.5 m/second. Mild pulmonary hypertension was defined as tricuspid regurgitant jet velocity > or = 2.5 to 2.9 m/second. Moderate pulmonary hypertension was defined as tricuspid regurgitant jet velocity > or = 3 m/second. Patients with pulmonary stenosis or right outflow obstruction were excluded. Characteristics were compared between patients with mild, moderate, and no pulmonary hypertension using 1-way analysis of variance for continuous variable and Fisher's exact test for categorical variables.
RESULTS: Of the 75 patients who had homozygous SS/Sbeta(0) thalassemia and were older than 6 years, echocardiograms were obtained for 62 (82.6%). Thirty percent (19 of 62) of patients had elevated tricuspid regurgitant jet velocity > or = 2.5 m/second. One third of these patients had tricuspid regurgitant jet velocity > or = 3 m/second. All patients with elevated tricuspid regurgitant jet velocity had SS disease. A high reticulocyte count, low oxygen saturation, and a high platelet count were significantly associated with elevated pulmonary artery pressures. There was no difference in age, gender, history of acute chest syndrome, hydroxyurea therapy, chronic blood transfusion, stroke, hemoglobin, and bilirubin between patients with and without elevated pulmonary artery pressures. A total of 47% patients with elevated tricuspid regurgitant jet velocity and 57% without elevated tricuspid regurgitant jet velocity had screening transcranial Doppler examinations. Transcranial Doppler examinations were normal for all patients.
CONCLUSIONS: High pulmonary artery pressures do occur in children with sickle cell disease. Screening by echocardiography can lead to early detection and intervention that may potentially reverse this disease process. There was no correlation between elevated pulmonary artery pressures and abnormal transcranial Doppler examination in our study.

Entities:  

Mesh:

Year:  2008        PMID: 18381543     DOI: 10.1542/peds.2007-0730

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

1.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

2.  Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years.

Authors:  Margaret T Lee; Tania Small; Muhammad A Khan; Erika B Rosenzweig; Robyn J Barst; Gary M Brittenham
Journal:  Br J Haematol       Date:  2009-06-25       Impact factor: 6.998

3.  Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.

Authors:  Amira Abdel Moneam Adly; Nayera Hazaa Khalil ElSherif; Eman Abdel Rahman Ismail; Yosra Abdelzaher Ibrahim; Gamal Niazi; Sara Hamed Elmetwally
Journal:  Redox Rep       Date:  2017-03-13       Impact factor: 4.412

4.  Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy.

Authors:  Mohsen Saleh ElAlfy; Amira Abdel Moneam Adly; Fatma Soliman ElSayed Ebeid; Deena Samir Eissa; Eman Abdel Rahman Ismail; Yasser Hassan Mohammed; Manar Elsayed Ahmed; Aya Sayed Saad
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

5.  Correlation of N-terminal fragment of B-type natriuretic peptide levels with clinical, laboratory, and echocardiographic abnormalities in children with sickle cell disease.

Authors:  Shinichi Takatsuki; David Dunbar Ivy; Rachelle Nuss
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

6.  NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.

Authors:  Roberto F Machado; Mariana Hildesheim; Laurel Mendelsohn; Alan T Remaley; Gregory J Kato; Mark T Gladwin
Journal:  Br J Haematol       Date:  2011-06-21       Impact factor: 6.998

7.  Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation.

Authors:  Mark C Johnson; Fenella J Kirkham; Susan Redline; Carol L Rosen; Yan Yan; Irene Roberts; Jeanine Gruenwald; Jan Marek; Michael R DeBaun
Journal:  Blood       Date:  2010-04-08       Impact factor: 22.113

Review 8.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

9.  Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.

Authors:  Niti Dham; Gregory Ensing; Caterina Minniti; Andrew Campbell; Manuel Arteta; Sohail Rana; Deepika Darbari; Mehdi Nouraie; Onyinye Onyekwere; Malgorzata Lasota; Gregory J Kato; Mark T Gladwin; Oswaldo Castro; Victor Gordeuk; Craig Sable
Journal:  Am J Cardiol       Date:  2009-06-24       Impact factor: 2.778

10.  Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.

Authors:  Xiaomei Niu; Mehdi Nouraie; Andrew Campbell; Sohail Rana; Caterina P Minniti; Craig Sable; Deepika Darbari; Niti Dham; N Scott Reading; Josef T Prchal; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.